HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine given eight weeks apart can elicit immune responses against the human immunodeficiency virus.

About Crazy-hacker

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments:

Post a Comment